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Abstract  
 
Background: Hospital-acquired viral respiratory tract infections (VRTIs) cause significant 
morbidity and mortality in neonatal patients. This includes escalation of respiratory support, 
increased length of hospital stay and need for home oxygen, as well as higher healthcare 
costs.  To date, no studies have compared population rates of VRTIs across age groups.  
 
Aim: Quantify the rates of hospital-acquired VRTIs in our neonatal population compared 
with other inpatient age groups in Nottinghamshire, UK. 
 
Methods: We compared all hospital inpatient PCR positive viral respiratory samples between 
2007 and 2013 and calculated age stratified rates based on population estimates.  
 
Results: From a population of 4,707,217 we identified a previously unrecognised burden of 
VRTI in neonatal patients, only second to the 0-1 year old group.  Although only accounting 
for 1.3% of the population, half of the infections were in infants <1 year old and NICU 
patients.  Human rhinovirus was the most dominant virus across the inpatient group, 
particularly in neonatal patients.  Despite a two- to three-fold increase in the rate of positive 
samples in all groups during the colder months (1.1/1000 October to March vs. 0.4/1000 
April to September), rates in the NICU did not change throughout the year at 4.3/1000. 
Pandemic H1N1 influenza rates were 20 times higher in neonatal patients and infants <1 year 
old. 
 
Conclusion: Good epidemiological and interventional data are needed to help inform visiting 
and infection control policies to reduce transmission of hospital-acquired viral infections to 




Hospital-acquired viral respiratory tract infections (VRTIs) on the neonatal intensive care 
unit (NICU) are associated with the need for escalation of respiratory support, increased 
length of hospital stay, increased bronchopulmonary dysplasia and almost double the 
requirement for home oxygen[1,2].  In addition, there are significant NICU resource 
implications for healthcare providers with additional associated costs of almost £28,000 per 
infant with a VRTI[1].   
 
Treatment for the majority of VRTIs is supportive. As such, they are not routinely tested for 
unless there is a specific clinical concern. Previous studies have found viral nasal carriage in 
52% of asymptomatic infants[3] and 8% of infants had a VRTI when screened in parallel as 
part of late-onset sepsis workup[2].  
 
On the NICU, VRTIs are hospital-acquired and so are most likely to originate from staff or 
visitors. In the UK, infection control and visiting policies relating to VRTIs vary widely[4]. 
The inpatient burden of hospital-acquired VRTIs in the NICU, compared with that of the 
local population in hospital with a VRTI, has not previously been established. In the context 
of the associated morbidity and mortality in this vulnerable population, especially during 
pandemics, it is important to quantify this risk. We aimed to quantify the burden of VRTIs on 







We performed a cross-sectional cohort study on all positive viral respiratory samples, 
analysed by polymerase chain reaction (PCR), from inpatients admitted to two large tertiary 
hospitals in Nottingham between 2007 and 2013. Patients were stratified into groups 
according to age: NICU inpatients admitted for >4 hours, 0-1 years (infants, not on NICU), 1-
4 years (pre-school children), 5-15 years (school-age children), 16-59 years and those ≥60 
years old.  
 
NICU rates were calculated as number of positive PCRs per 1000 neonatal admissions to the 
two tertiary units during the study period. Rates for all other age groups were calculated as 
the number of positive PCRs in hospital inpatients per 1000 residents using local age-specific 
population estimates for Nottinghamshire in the respective years from the Office of National 
Statistics[5].     
 
The seasonal patterns were split into the UK’s non-peak (April to September) and peak 
(October to March) viral infection periods. During the peak months of 2009/2010, 2010/2011 
and 2011/2012, we instigated a restricted visiting policy with only parents/carers allowed to 
visit their baby in response to the H1N1 pandemic[6].  Rates were therefore calculated with 




The total local population was 4,707,217 during the study period with 6,924 individual PCR 
positive respiratory samples on inpatients during this time. Overall rates were highest 
amongst infants 0-1yrs (61.0/1000) followed by the NICU population (17.1/1000, Table 1). 
Half of the positive PCR samples were from those <1 year of age but these accounted for 
only 1.3% of the population.  Human Rhinovirus (HRV) was the most common virus in all 
groups other than those in the 0-1 age group, in whom Respiratory Syncytial Virus (RSV) 
was more common. In the NICU, HRV was particularly prevalent with a rate 2.5 times higher 
than all the other viruses combined. Although small numbers, H1N1 (pandemic influenza) 
rates were up to 20 times higher in the NICU and 0-1 year population compared to other 
groups.  
 
Seasonality data (figure 1) showed that despite a two- to three-fold increase in the rate of 
positive samples in all groups during the peak months (1.1/1000 October to March vs. 
0.4/1000 April to September), NICU rates remained similar throughout the year at 4.3/1000. 
Overall NICU VRTI rates during the peak months were 2.6/1000 with normal visiting, 
dropping to 1.4/1000 with restrictions.  HRV rates were particularly affected by this policy 




These are the first data to quantify the inpatient population rates of VRTIs and identify a 
previously unreported high rate in the NICU including during a pandemic influenza period.  
Early life is a period of first exposure to many viruses and this reflects the prevalence in this 
population with half of the cases in the under 1 year group. 
 
The high rate in the NICU raises questions about the source of transmission of these viruses 
when the babies have never left hospital. These are hospital-acquired infections and must 
come from visitors or staff unlike the other age groups where most are community-acquired.  
There is a lack of good quality evidence to inform NICU policies regarding viral transmission 
prevention measures, screening protocols, and infection control and isolation procedures 
following identification of cases[7].  This has been observed with wide variations in UK 
NICU policies[4]. During the pandemic influenza seasons, our hospitals trust like others 
implemented a policy of restricting visiting to parents only, reducing the incidence of VRTI 
by 39%[6]. However, pandemic influenza remained a small but significant risk, with five 
babies positive for H1N1 during the study period. Moreover, the rate on the NICU was 
similar to that of the community-exposed 0-1 year group being up to 20 times higher than 
other groups although we must be cautious about this rate in view of the small numbers. 
 
In our study, HRV accounts for three quarters of infections and is the dominant pathogen in 
all age groups apart from the 0-1 year. Although HRV causes mild symptoms in older 
children and adults, in ex-preterm infants it may cause more severe respiratory illness[8]. 
Preterm infants often have significant oxygen requirements which could exacerbate lung 
inflammation during HRV infection[9]. These factors could account for some of the 
observations that NICU graduates with a VRTI spend longer in hospital and leave with 
significantly worse respiratory disease.  This could increase their risk of later childhood and 
adulthood chronic respiratory disease. 
 
Our study is limited by small numbers in two UK centres with testing dependent on the 
individual clinician. Our overall VRTI rates focus only on inpatients and so the community 
burden may be different, however, we aimed to look at those most severely affected and so 
require hospital treatment.  Whilst the NICU cases are hospital-acquired infections we do not 
have details on where the other patient groups acquired their infection i.e. in the community 
or hospital. Validation of these rates are required from similar centres.   
 
Our data highlight the significant burden of inpatient VRTIs in the NICU.  The dominance of 
HRV across the lifespan, particularly in the NICU, is a worry as studies have focused on RSV 
prophylaxis which is more prevalent in the early childhood group.  Good epidemiological and 
interventional data are needed to help inform visiting and infection control policies to reduce 
transmission of viral infections to this population, particularly during pandemic seasons. The 
UK’s National Institute of Health Research's pandemic influenza preparedness portfolio[10] 
is poised to study the next pandemic as it happens and so provide more timely and useful 
data. Although small numbers, the high rate of infections and significant morbidity in the 
NICU warrants neonatal inclusion in this important work as well as further studies to reduce 
the spread and burden in this high-risk population.  
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Table 1: Rate of positive viral respiratory tract samples per thousand people according to age category  
 
 Population Age Category 
  
Virus 
















Adenovirus 0.31 3.01 0.69 0.07 0.02 0.01 0.09 414 
Influenza 0.31 2.13 0.54 0.12 0.05 0.09 0.11 528 
H1N1 
Influenza 
0.76 0.77 0.19 0.04 0.04 0.02 0.05 
242 
Parainfluenza 1.83 4.43 0.63 0.07 0.03 0.08 0.13 601 
Rhinovirus 12.20 21.51 2.59 0.30 0.11 0.15 0.51 2,423 
RSV 1.07 27.02 1.97 0.09 0.04 0.08 0.45 2,107 
Others 0.61 4.52 0.85 0.07 0.03 0.06 0.13 609 
Rate 17.08 60.99 7.45 0.75 0.31 0.49 1.47 - 
Total positive 112 3,376 1,581 442 842 571 6,924 6,924 
(Others= Cytomegalovirus, Coronavirus, Epstein-Barr virus, Herpes simplex virus and Murine pneumonia virus) 
 
  
Figure 1: Age stratified rates of positive viral respiratory tract samples per thousand people (log scale) during non-peak (April to September) 
and peak (October to March) months. 
 
 
